HDAC9 and cancer: In addition, our results suggest that the concentration of HDAC inhibitors required for anti-proliferation for cancer cells and the concentration necessary for differentiation of stem cells are different, and when appropriate concentrations are applied to stem cells, they do not cause cytotoxicity [1].